Search results

From Self-sufficiency
Jump to: navigation, search
  • ...(2-ethylthioisonicotinamide, Trecator SC) is an [[antibiotic]] used in the treatment of [[tuberculosis]]. ...=Vannelli TA, Dykman A, Ortiz de Montellano PR |title=The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase |journal=J. Biol.
    2 KB (278 words) - 16:44, 27 September 2010
  • ...name '''Canesten''') is an [[antifungal]] medication commonly used in the treatment of fungal infections of both humans and animals such as [[candidiasis|vagin ==Drug interactions==
    4 KB (525 words) - 11:13, 20 September 2010
  • ...ng|fluːˈkɒnəzoʊl}}) is a [[triazole]] [[antifungal drug]] used in the treatment and prevention of superficial and systemic fungal infections. In a bulk pow ...ess to avoid producing any [[Chirality (chemistry)|chiral]] centers in the drug so that subsequent synthesis and purification would not encounter difficult
    11 KB (1,533 words) - 16:44, 27 September 2010
  • | legal_status = [[Prescription drug|POM]] <small>([[United Kingdom|UK]])</small>, ℞-only <small>(U.S.)</small ...'Grisovin''', a proprietary name of Glaxo Laboratories) is an [[antifungal drug]] that is administered orally. It is used both in animals and in humans, t
    5 KB (678 words) - 14:58, 19 September 2010
  • ...toxicity]] profile, there are currently no injectable formulations of this drug on the US market.<ref>Nystatin on RxList.com http://www.rxlist.com/script/m ...ageal]] ''[[Candida (genus)|Candida]]'' infections usually respond well to treatment with nystatin. ''[[Cryptococcus]]'' is also sensitive to nystatin. In the [
    7 KB (941 words) - 16:44, 27 September 2010
  • ...ungisome, Amphocil, Amphotec) is a [[polyene]] [[antifungal]] [[medication|drug]], often used [[intravenous]]ly for systemic [[fungi|fungal]] [[infection]] Currently the drug is available as plain Amphotericin B, as cholesteryl sulfate complex, as li
    13 KB (1,785 words) - 16:44, 27 September 2010
  • ...[[pyrimidine analogue]], is a synthetic [[Antifungal drug|antimycotic]] [[drug]]. ...synthesized in 1957 but its antifugnal properties discovered in 1964. The drug is dispensed in capsules of 250 mg and 500 mg strength. The injectable form
    10 KB (1,394 words) - 16:44, 27 September 2010
  • ...chemical in photography. KI is a component in some disinfectants and hair treatment hair chemicals. KI is also used as a [[fluorescence quenching]] agent in bi *Saturated solutions of potassium iodide can be an emergency treatment for [[hyperthyroidism]] (so-called [[thyroid storm]]), as high amounts of i
    23 KB (3,281 words) - 16:44, 27 September 2010
  • ...or the treatment of [[herpes simplex virus]] infections, as well as in the treatment of [[herpes zoster|herpes zoster (shingles)]]. ...er and pioneer in antiviral therapy, was the first to successfully use the drug in humans.
    14 KB (1,878 words) - 16:44, 27 September 2010
  • ...DA) on December 18, 1998 and is thus the fifteenth approved antiretroviral drug in the United States. Its patent expired in the United States on 2009-12-2 ...on, in combination with other antiretroviral agents, are indicated for the treatment of HIV-1 infection.
    8 KB (1,124 words) - 16:44, 27 September 2010
  • ...ective against [[HIV]] and used in combination with other [[antiretroviral drug]] therapy as part of highly active antiretroviral therapy (HAART). The related pro-drug of didanosine, 2'3'-dideoxyadenosine (ddA), was initially synthesized by M.
    9 KB (1,239 words) - 16:44, 27 September 2010
  • ...'), is a [[nucleoside]] [[reverse transcriptase inhibitor]] (NRTI) for the treatment of [[HIV]] infection in adults and children. ...proved by the [[Food and Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) on July 12, 2006 under the brand name '''Atripla'''.
    5 KB (667 words) - 16:44, 27 September 2010
  • ...een used for treatment of chronic [[hepatitis B]] at a lower dose than for treatment of [[HIV]]. It improves the seroconversion of e-antigen positive hepatitis ...tually led to the first oral antiviral agent for the treatment of HBV. The drug was later licensed to the British pharmaceutical company Glaxo by Biochem P
    9 KB (1,248 words) - 16:44, 27 September 2010
  • ...release version for once-a-day dosing in 2001. The fourth [[antiretroviral drug]] on the market, its patent expired in the United States on 2008-06-25. ...dystrophy]], and for this reason it is no longer considered an appropriate treatment for most patients in developed countries.
    4 KB (574 words) - 16:44, 27 September 2010
  • | legal_status = ℞-only <small>(U.S.)</small>, [[Prescription drug|POM]] <small>([[United Kingdom|UK]])</small> ...under the trade name '''Viread''', belongs to a class of [[antiretroviral drug]]s known as nucleotide analogue [[reverse transcriptase inhibitor]]s (nRTIs
    6 KB (871 words) - 16:45, 27 September 2010
  • ...ghly active [[Antiretroviral drug|antiretroviral therapy]] (HAART) for the treatment of a human immunodeficiency virus ([[HIV]]) type 1. ...ides HAART in a single tablet taken once a day. It results in a simplified drug regimen for many patients.
    10 KB (1,441 words) - 16:45, 27 September 2010
  • ...on = [[Kidney|Renal]]: <6% (Parent drug) <br> [[Bile|Biliary]] <5% (Parent drug) As with other [[antiretroviral drug]]s, HIV rapidly develops resistance if nevirapine is used alone, so recomme
    15 KB (2,090 words) - 16:45, 27 September 2010
  • ...pharmacology)|protease inhibitor]] used as a component of [[antiretroviral drug|highly active antiretroviral therapy]] (HAART) to treat [[HIV]] infection a ...y prior antiretroviral drug; using it with dual NRTIs set the standard for treatment of HIV/AIDS and raised the bar on design and introduction of subsequent ant
    3 KB (320 words) - 15:07, 6 July 2010
  • | legal_status = ℞-only <small>(U.S.)</small>, [[Prescription drug|POM]] <small>([[United Kingdom|UK]])</small> '''Lopinavir''' ('''ABT-378''') is an [[Antiretroviral drug|antiretroviral]] of the [[Protease inhibitor (pharmacology)|protease inhibi
    8 KB (1,109 words) - 16:45, 27 September 2010
  • ...ed dose combination (antiretroviral)|fixed dose combination]] drug for the treatment of [[HIV]] infection. It combines [[Gilead Sciences]]'s [[tenofovir]] and [ ...U.S. [[Food and Drug Administration|FDA]] on July 12, 2006. In the UK, the drug cost to the NHS is {{GB£}}620 per month.
    6 KB (773 words) - 16:45, 27 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)